News about 'JHU'

28 Aug 2012
On September 5 and 6, 2012, the “Demystifying Pyrazinamide – Challenges and Opportunities” Workshop will be held at Johns Hopkins University and is sponsored by National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation, Johns Hopkins University Center for AIDS...
6 Jun 2012
Delamanid (OPC-67683) This week, efficacy data from the recently completed Phase 2 randomized placebo-controlled trial in MDR patients evaluating delamanid with background treatment compared to placebo with background treatment was published yesterday in the New England Journal of Medicine ...
7 Nov 2011
Gyanu Lamicchane Summary: Microbial geneticist Dr. Gyanu Lamichhane of the Johns Hopkins Center for Tuberculosis Research is one of 49 recipients of the New Innovator Award, which is given to promising scientists in the early stages of their careers and is supported directly with $1.5 million in...
15 Aug 2011
pyrazinamide (PZA) Shi W, Zhang X, Jiang X, Yuan H, Lee JS, Barry CE 3rd, Wang H, Zhang W, Zhang Y. Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis . Science. 2011 Aug 11. [Epub ahead of print] This week we highlight an article published out of Ying Zhang’s laboratory at Johns...
14 Mar 2011
Summary: Dr. Eric Nuermberger is Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, at Johns Hopkins University School of Medicine. The WGND had the opportunity to talk with Dr. Nuermberger on a recent article entitled “PA-824 exhibits time-dependent...
14 Jun 2010
Johns Hopkins Medicine On Friday, June 11 th , the Johns Hopkins University Center for Tuberculosis Research hosted their annual scientific meeting and the WGND was there to cover the event. Approximately 100-200 people were present including persons from NIH and small pharmaceutical companies...
25 May 2010
Dr. Bill Bishai DURBAN, SOUTH AFRICA (May 26, 2010) – The University of KwaZulu-Natal (UKZN) and the Howard Hughes Medical Institute today announced the appointment of William R. Bishai, M.D., Ph.D., as the first permanent director of the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K...
3 Mar 2010
Detailed view of the ligand-binding site of EthR co-crystallized with BDM31381 (EthRInhibitor) Developing new TB drugs is inhibited by so many factors – namely: The flow through the TB drug pipeline is slow at best. Despite decades of hard work, we still use the demanding regimen developed 50 years...
24 Feb 2010
Dr. Jacques Grosset Dr. Jacques Grosset’s biography is excerpted from his staff page on the Johns Hopkins Medicine website . Since the beginning of my professional life I have been involved in research to improve the control of tuberculosis, mainly by improving treatment of tuberculosis and...
18 Feb 2010
Dr. Jacques Grosset On November 13, 2009, people gathered at Johns Hopkins University to celebrate the work and life of Dr. Jacques Grosset , a legend in TB research.
17 Feb 2010
Can Vitamin-D from sunshine help TB treatment?(photo: Jon Sullivan, courtesy of Public Domain Photos) One of the characteristics making M. tuberculosis such an insidious killer is its uncanny ability to thwart many of our best defenses. Whether through hiding itself in our lungs for years or...
4 Feb 2010
Susan Dorman Susan Dorman serves on the faculty at Johns Hopkins University in TB Research is also the Medical Director of the Baltimore City TB Clinic. This interview was filmed at JHU on November 13, 2009.